Skip to main content
×
×
Home

Depression and obesity: can the cycle be broken?

  • Karen Romain, Timothy Webb and Manoj Kumar
Summary

Obesity and depression are conditions that have been linked through a great number of interesting mechanisms. To fully understand the implications of treatment choices it is necessary to continue to investigate the physiology of these two conditions. By examining the background of these problems and considering factors such as stress response, neurological change and systemic inflammation, we propose a cycle linking depression and obesity. With reference to this cycle, we discuss management options, focusing particularly on prescribing choices and current guidelines. An assessment of the medication options is provided demonstrating that prescribing choices can have a significant impact on ongoing physical health. The aim of this discussion is to raise awareness of current research and progress and to see whether the cycle of depression and obesity can be broken.

LEARNING OBJECTIVES

  • Update knowledge of the mechanisms linking depression and obesity
  • Understand the impact of medication on the cycle linking the two
  • Consider how we can improve outcomes for patients with depression and/or obesity

DECLARATION OF INTEREST

None.

Copyright
Corresponding author
Correspondence Dr Karen Romain, St Michael’s Hospital, St Michael's Rd, Warwick CV34 5QW. Email: karen.romain@nhs.net
References
Hide All
Amaral, MOP, Garrido, AJDA, Pereira, CDF, et al. (2016) Quality of life, sleepiness and depressive symptoms in adolescents with insomnia: a cross sectional study. Atención Primaria, 49: 3541.
Appelhands, BM, Whited, MC, Schneider, KL, et al. (2012) Depression severity, diet quality, and physical activity in women with obesity and depression. Journal of the Academy of Nurtion and Dietetics, 112: 693–8.
Askari, J, Hassanbeigi, A, Khosravi, HM, et al. (2013) The relationship between obesity and depression. Procedia – Social and Behavioural Sciences, 84: 796800.
Bao, Y, Han, Y, Ma, J, et al. (2017) Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: meta-analysis and systematic review. Neuroscience and Biobehavioural Reviews, 75: 257–73.
Bazire, S (2016) Psychotropic Drug Directory. Lloyd-Reinhold Publications.
Belviq (2016) Important Safety Information. [Online] Available at: (https://www.belviq.com/) Accessed April 2017.
Benson, S, Arck, PC, Tan, S, et al. (2009) Effects of obesity on neuroendocrine, cardiovascular, and immune cell responses to acute psychological stress in premenopausal women. Psychoneuroendocrinology, 34: 181–9.
Bray, G, Perreault, L (2016) Obesity in Adults: Drug Therapy. UpToDate [Online] (https://www.uptodate.com/contents/obesity-in-adults-drug-therapy). Accessed Sept 2016.
Carey, M, Small, H, Lin Yoong, S, et al. (2014) Prevalence of comorbid depression and obesity in general practice: a cross sectional survey. British Journal of General Practice, 64(620): e122–7.
CenterWatch (2017) 2017 FDA Approved Drugs. Available at: https://www.centerwatch.com/drug-information/fda-approved-drugs/. Accessed April 2017.
Choice and Medication (2016) Information for people who use services, carers and professionals. Available at: http://www.choiceandmedication.org/south-staffs/pdf/. Accessed September 2016.
Cleare, A, Pariante, CM, Young, AH, et al. (2015) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology, 29: 459525.
de Carvalho-Ferreira, JP, Landi Masquio, DC, da Silveira Campos, RM, et al. (2014) Is there a role for leptin in the reduction of depression symptoms during weight loss therapy in obese adolescent girls and boys? Peptides, 65: 20–8.
DiNicolantonio, JJ, Chatterjee, S, O'Keefe, J, et al. (2014) Lorcaserin for the treatment of obesity? A closer look at its side effects. Openheart, 1(1): e000173.
Electronic Medicines Compendium (EMC) (2017) Summaries of Product Characteristics. Individual online documents for each medication listed separatley [Online] http://www.medicines.org.uk/emc/ Accessed April 2017.
García-Toro, M, Vicens-Pons, E, Gili, M, et al. (2016) Obesity, metabolic syndrome and Mediterranean diet: impact on depression outcome. Journal of Affective Disorders, 194, 105–8.
Jantaratnotai, N, Mosikanon, K, Lee, Y, et al. (2017) The interface of depression and obesity. Obesity Research & Clinical Practice, 11: 110.
Jensen-Otsu, E, Austin, GL (2015) Antidepressant use is associated with increased energy intake and similar levels of physical activity. Nutrients, 7, 9662–71.
Joint Formulary Committee (2017) British National Formulary (74th edn). BMJ Group and Pharmaceutical Press.
Karling, P, Wikgren, M, Adolfsson, R, et al. (2016) Hypothalamus-pituitary-adrenal axis hypersuppression is associated with gastrointestinal symptoms in major depression. Journal of Neurogastroenterology and Motility, 22: 292303.
Kluge, M, Schüssler, P, Dresler, M, et al. (2011) Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. Journal of Psychiatric Research, 45: 421–6.
Lee, S, Paek, J, Han, S (2015) Sleep hygiene and its association with daytime sleepiness, depressive symptoms and quality of life in patients with mild obstructive sleep apnea. Journal of the Neurological Sciences, 359: 445–9.
Liu, Y, Al-Sayegh, H, Jabrah, R, et al. (2014) Association between C-reactive protein and depression: modulated by gender and mediated by body weight. Psychiatry Research, 219: 103–8.
Lopresti, AL, Hood, SD, Drummond, PD (2013) A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. Journal of Affective Disorders, 148: 1227.
Mannan, M, Mamun, A, Doi, S, et al. (2015) Is there a bi-directional relationship between depression and obesity among adult men and women? Systematic review and bias-adjusted meta analysis. Asian Journal of Psychiatry, 21: 5166.
Medicines & Healthcare Products Regulatory Agency (MHRA) (2017) Medicines Information: Product details: Phentermine. Available at: http://www.mhra.gov.uk/spc-pil/?prodName=IONAMIN%2015&subsName=PHENTERMINE&pageID=SecondLevel. Accessed April 2017.
Michopoulos, V (2016) Stress-induced alterations in estradiol sensitivity increase risk for obesity in women. Physiology & Behaviour, 166: 5664.
National Institute for Health and Care Excellence (2005) Depression in Children and Young People: Identification and Management (Clinical Guideline CG28). NICE.
National Institute for Health and Care Excellence (NICE) (2011) Depression in Adults (Quality Standard QS8). NICE.
National Institute for Health and Care Excellence (NICE) (2014) Obesity: Identification, Assessment and Management (Clinical Guideline CG189). NICE.
National Institute for Health and Care Excellence (NICE) (2015) Obesity in Children and Young People: Prevention and Lifestyle Weight Management Programmes (Quality Standard QS94). NICE.
NHS England (2014) NHS England pledge to help patients with serious mental illness. NHS England News, 20 Jan.
Nigatu, YT, Reijneveld, SA, de Jonge, P, et al. (2016) The combined effects of obesity, abdominal obesity and major depression/anxiety on health-related quality of life: the LifeLines Cohort Study. PLoS One, 11(2): e0148871.
Opel, N, Redlich, R, Grotegerd, D, et al. (2015) Obesity and major depression: body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations. Psychoneuroendocrinology, 51: 219–26.
Qsymia (2014) Risk Evaluation and Mitigation Strategy (REMS). Available at: http://www.qsymiarems.com/. Accessed April 2017.
Palm, A, Janson, C, Lindberg, E (2015) The impact off obesity and weight gain on development of sleep problems in a population-based sample. Sleep Medicine, 16: 593–7.
Pennix, BWJH, Milaneschi, Y, Lamers, F, et al. (2013) Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Medicine, 11: 129.
Privitera, GJ, McGrath, HK, Windus, BA, et al. (2015) Eat now or later: self-control as an overlapping cognitive mechanism of depression and obesity. PLos ONE, 10(3).
Rivera, M, Cohen-Woods, S, Kapur, K, et al. (2012) Depressive disorder moderates the effect of the FTO gene on body mass index. Molecular Psychiatry, 17, 604–11.
Robinson, RL, Grabner, M, Rao Palli, S, et al. (2016) Covariates of depression and high utilizers of healthcare: impact on resource use and costs. Journal of Psychosomatic Research, 85, 3543.
Rogerson, D, Soltani, H, Copeland, R (2016) The weight-loss experience: a qualitative exploration. BMC Public Health, 16: 371.
Royal College of Physicians (2013) Action on Obesity: Comprehensive Care for All. Report of a Working Party January 2013. RCP.
Royal Pharmaceutical Society (2000) Withdrawal of appetite suppressants. Pharmaceutical Journal, 264: 572.
Schmid, SM, Hallschmid, M, Shultes, B (2015) The metabolic burden of sleep loss. Lancet Diabetes Endocrinology, 3: 5262.
Simon, GE, Ludman, EJ, Linde, JA, et al. (2008) Association between obesity and depression in middle aged women. General Hospital Psychiatry, 30: 32–9.
Singh, G, Jackson, CA, Dobson, A, et al. (2014) Bidirectional association between weight change and depression in mid-aged women: a population-based longitudinal study. International Journal of Obesity, 38: 591–6.
Steward, T, Picó-Pérez, M, Mata, F, et al. (2016) Emotion regulation and excess weight: impaired affective processing characterised by dysfunctional insula activation and connectivity. PLoS One, 11(3): e0152150.
Taylor, VH, Forhan, M, Vigod, SN, et al. (2013) The impact of obesity on quality of life. Best Practice & Research Clinical Endocrinology & Metabolism, 27: 139–46.
Torres, SJ, Nowson, CA (2007) Relationship between stress, eating behaviour, and obesity. Nutrition, 23: 887–94.
van Grieken, RA, Beune, EJAJ, Kirkenier, ACE, et al. (2014) Patients’ perspectives on how treatment can impede their recovery from depression. Journal of Affective Disorders, 167: 153–9.
White, W, Elmore, L, Luthin, DR, et al. (2013) Psychotropic-induced weight gain: a review of management strategies. Consultant, 53: 153–60.
World Health Organization (2017a) Obesity and overweight [Online Fact Sheet]. WHO (http://www.who.int/mediacentre/factsheets/fs311/en/). Accessed May 2017.
World Health Organization (2017b) Depression [Online Fact Sheet]. WHO (http://www.who.int/mediacentre/factsheets/fs369/en/). Accessed May 2017.
Xing, S, Sharp, LK, Touchette, DR (2016) Weight loss drugs and lifestyle modification: perceptions among a diverse adult sample. Patient Education and Counselling, 100, 592–7.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 2056-4678
  • EISSN: 2056-4686
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 66
Total number of PDF views: 209 *
Loading metrics...

Abstract views

Total abstract views: 554 *
Loading metrics...

* Views captured on Cambridge Core between 1st March 2018 - 17th July 2018. This data will be updated every 24 hours.

Depression and obesity: can the cycle be broken?

  • Karen Romain, Timothy Webb and Manoj Kumar
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *